Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima

Bernhard Dorweiler; Michael Torzewski; Manfred Dahm; Charles James Kirkpatrick; Karl J. Lackner; Christian-Friedrich Vahl

doi:10.1160/TH07-06-0387

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2008; 99(02): 373-381
DOI: 10.1160/TH07-06-0387

Cardiovascular Biology and Cell Signalling

Schattauer GmbH

Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima

Bernhard Dorweiler

¹Department of Cardiothoracic and Vascular Surgery

,

Michael Torzewski

²Institute of Clinical Chemistry and Laboratory Medicine

,

Manfred Dahm

¹Department of Cardiothoracic and Vascular Surgery

,

Charles James Kirkpatrick

³Institute of Pathology, Johannes Gutenberg-University, Mainz, Germany

,

Karl J. Lackner

²Institute of Clinical Chemistry and Laboratory Medicine

,

Christian-Friedrich Vahl

¹Department of Cardiothoracic and Vascular Surgery

› Institutsangaben

Abstract

Summary

It was the objective of this study to examine the role of human neutrophil granulocytes (PMN) in an in-vitro model of human neo-intima developed for the study of atherosclerosis. Human granulocytes were subjected to a co-culture model of human endothelial and smooth muscle cells. Subendothelial lipid accumulation was achieved by addition of native LDL to the culture medium. Tissue samples were analyzed by immunohistochemistry and scanning/transmission electron microscopy, and culture supernatants were examined for the presence of interleukin- 8 (IL-8), MCP-1, GRO-α, elastase and matrixmetalloproteinase-8 (MMP-8). Following addition of 2 mg/ml LDL, adherence, transmigration and infiltration depth of PMN was increased significantly when compared to controls. LDL challenging was paralleled by a time- and dose-dependent secretion of IL-8 from intimal smooth muscle cells. PMN infiltration was mediated by the IL-8-signalling pathway and accompanied by release of elastase and MMP-8 into the supernatant and induction of endothelial cell apoptosis. In conclusion, LDL-induced secretion of IL-8 by intimal smooth muscle cells provides a potential mechanism of PMN-recruitment into culprit lesions. The concomitant release of potent matrix-degrading enzymes and the induction of EC apoptosis may have implications for plaque destabilization and cardiovascular events.

keywords

Atherosclerosis - endothelium - proteases - leukocyte recruitment - apoptosis

Volltext

Referenzen

References
1 Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007; 116: 1832-1844.
2 Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340: 115-126.
3 Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-241.
4 Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002; 8: 1211-1217.
5 Ward MR, Pasterkamp G, Yeung AC. et al. Arterial remodeling – mechanisms and clinical implications. Circulation 2000; 102: 1186-1191.
6 Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis – The good, the bad und the ugly. Circ Res 2002; 90: 251-262.
7 Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006; 6: 508-519.
8 Schoenhagen P, Ziada KM, Kapadia SR. et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes. Circulation 2000; 101: 598-603.
9 Van der Laan PA, Reardon CA. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J Lipid Res 2005; 46: 829-838.
10 Mehta J, Dinerman J, Mehta P. et al. Neutrophil function in ischemic heart disease. Circulation 1989; 79: 549-556.
11 Buffon A, Biasucci LM, Liuzzo G. et al. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347: 5-12.
12 Mazzone A, DE Servi S, Ricevuti G. et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88: 358-363.
13 Madjid M, Awan I, Willerson JT. et al. Leukocyte count and coronary heart disease. J Am Coll Cardiol 2004; 44: 1945-1956.
14 Horne BD, Anderson JL, John JM. et al. Which white blood cell subtypes predict increased cardiovascular risk ?. J Am Coll Cardiol 2005; 45: 1638-1643.
15 Van der Wal AC, Becker AE, Van der Loos CM. et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
16 Naruko T, Ueda M, Haze K. et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002; 106: 2894-2900.
17 Eriksson EE, Xie X, Werr J. et al. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J 2001; 15: 1149-1157.
18 Berliner JA, Territo MC, Sevanian A. et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990; 85: 1260-1266.
19 Dorweiler B, Torzewski M, Dahm M. et al. A novel in vitro model for the study of plaque development in atherosclerosis. Thromb Haemostas 2006; 95: 182-189.
20 Bhakdi S, Greulich S, Muhly M. et al. Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J Exp Med 1989; 169: 737-754.
21 Zigmond SH, Hirsch JG. Leukocyte locomotion and chemotaxis – New methods for evaluation and demonstration of a cell-derived chemotactic factor. J Exp Med 1973; 137: 387-410.
22 Pawlowski NA, Kaplan G, Abraham E. et al. The selective binding and transmigration of monocytes through the junctional complexes of human endothelium. J Exp Med 1988; 168: 1865-1882.
23 Muller WA, Weigl SA. Monocyte-selective transendothelial migration: Dissection of the binding and transmigration phases by an in vitro assay. J Exp Med 1992; 176: 819-828.
24 Smith CW, Rothlein R, Hughes BJ. et al. Recognition of an endothelial determinant for CD18-dependant human neutrophil adherence and transendothelial migration. J Clin Invest 1988; 82: 1746-1756.
25 Kramps JA, Van der Valk P, Van der Sandt MM. et al. Elastase as a marker for neutrophilic myeloid cells. J Histochem Cytochem 1984; 32: 389-394.
26 Baggiolini M, Walz A, Kunkel SK. Neutrophil-activating peptide-1/Interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049.
27 Apostolopoulos J, Davenport P, Tipping PG. Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vasc Biol 1996; 16: 1007-1012.
28 Wang N, Tabas I, Winchester R. et al. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem 1996; 271: 8837-8842.
29 Ryoo SW, Kim DU, Won M. et al. Native LDL induces interleukin-8 expression via H2O2, p38 Kinase and activator protein-1 in human aortic smooth muscle cells. Cardiovasc Res 2004; 62: 185-193.
30 Chen CN, Chang SF, Lee PL. et al. Neutrophils, lymphocytes, and monocytes exhibit diverse behaviors in transendothelial and subendothelial migrations under coculture with smooth muscle cells in disturbed flow. Blood 2006; 107: 1933-1942.
31 Terashima T, English D, Hogg JC. et al. Release of polymorphnuclear leukocytes from the bone marrow by interleukin-8. Blood 1998; 92: 1062-1069.
32 Detmers PA, Lo SK, Olsen-Egbert E. et al. Neutrophil-activating protein 1/Interleukin-8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 1990; 171: 1155-1162.
33 Lindstedt KA, Leskinen MJ, Kovanen PT. Proteolysis of the pericellular Matrix – A novel element determining cell survival and death in the pathogenesis of plaque erosion and rupture. Arterioscler Thromb Vasc Biol 2004; 24: 1350-1358.
34 Molloy KJ, Thompson MM, Jones JL. et al. Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity. Circulation 2004; 110: 337-343.
35 Verhoeven B, Hellings WE, Moll FL. et al. Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaque in asymptomatic and amaurosis fugax patients. J Vasc Surg 2005; 42: 1077-1081.
36 Sluijter JPG, Pulskens WPC, Schoneveld AH. et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions. Stroke 2006; 37: 235-239.
37 Herman MP, Sukhova GK, Libby P. et al. Expression of neutrophil collagenase (Matrix Metalloproteinase-8) in human atheroma. Circulation 2001; 104: 1899-1904.
38 Owen CA, Campbell EJ. The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol 1999; 65: 137-150.
39 Dollery CM, Owen CA, Sukhova GK. et al. Neutrophil elastase in human atherosclerotic plaques – production by macrophages. Circulation 2003; 107: 2829-2836.
40 Yang JJ, Kettritz R, Falk RJ. et al. Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. Am J Pathol 1996; 149: 1617-1626.
41 Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 2007; 97: 714-721.
42 Aukrust P, Yndestad A, Smith C. et al. Chemokines in cardiovascular risk prediction. Thromb Haemost 2007; 97: 748-754.